文献速递临床试验与 GCP

内镜下黏膜切除术后热消融对比无辅助治疗对晚期无蒂及侧向发育型结直肠腺瘤复发的影响(RESPECT):一项国际随机对照试验方案

Recurrences of advanced sessile and lateral spreading colorectal adenoma after endoscopic mucosal resection (EMR) thermal ablation versus no adjuvant therapy (RESPECT): a protocol of an international randomized controlled trial.
PubMed 文献 · Trials · 2024-02-17

RESPECT是一项在荷兰和德国开展的多中心、平行组、国际单盲随机对照优效性试验,计划纳入306例因20-60 mm侧向发育型病变或无蒂结直肠息肉接受分块EMR的患者,术中随机分为圈套器尖端软凝固(STSC)热消融全切除边缘组与对照组,主要结局为6个月后首次监测结肠镜经光学和组织学确认的息肉复发。

要点

  • 分块EMR治疗大结直肠病变的息肉复发率可高达20%。
  • STSC热消融全切除边缘可能降低复发率。
  • 该试验在日常实践中评估STSC的疗效与安全性。

核心结论

  • RESPECT试验将评估STSC在日常临床实践中是否能有效降低大结直肠病变分块EMR后的复发率。

研究设计与样本

  • 多中心、平行组、国际单盲随机对照优效性试验,在荷兰和德国开展。
  • 计划纳入306例因20-60 mm侧向发育型病变或无蒂结直肠息肉接受分块EMR的患者。
  • 在内镜下完整切除息肉后于术中随机分为干预组或对照组。

主要发现

  • 干预组EMR后创面接受STSC热消融整个切除边缘。
  • 主要结局为6个月后首次监测结肠镜经光学和组织学确认的息肉复发。
  • 次要结局包括技术成功率和并发症发生率。

临床怎么用

  • 研究允许内镜医师在术中采用辅助技术清除残留腺瘤组织。
  • 随访期间腺瘤性息肉复发将由组织学鉴定定义。
  • 研究由专家和非专家内镜医师在日常临床实践中实施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nowadays, large benign lateral spreading lesions (LSLs) and sessile polyps in the colorectum are mostly resected by endoscopic mucosal resection (EMR). A major drawback of EMR is the polyp recurrence rate of up to 20%. Snare tip soft coagulation (STSC) is considered an effective technique to reduce recurrence rates. However, clinical trials on STSC have mainly been conducted in expert referral centers. In these studies, polyp recurrence was assessed optically, and additional adjunctive techniques were excluded. In the current trial, we will evaluate the efficacy and safety of STSC in daily practice, by allowing adjunctive techniques during EMR and the use of both optical and histological polyp recurrence to assess recurrences during follow-up. METHODS: The RESPECT study is a multicenter, parallel-group, international single blinded randomized controlled superiority trial performed in the Netherlands and Germany. A total of 306 patients undergoing piecemeal EMR for LSLs or sessile colorectal polyps sized 20-60 mm will be randomized during the procedure after endoscopic complete polyp resection to the intervention or control group. Post-EMR defects allocated to the intervention group will be treated with thermal ablation with STSC of the entire resection margin. Primary outcome will be polyp recurrence by optical and histological confirmation at the first surveillance colonoscopy after 6 months. Secondary outcomes include technical success and complication rates. DISCUSSION: The RESPECT study will evaluate if STSC is effective in reducing recurrence rates after piecemeal EMR of large colorectal lesions in daily clinical practice performed by expert and non-expert endoscopists. Moreover, endoscopists will be allowed to use adjunctive techniques to remove remaining adenomatous tissue during the procedure. Finally, adenomatous polyp recurrence during follow-up will be defined by histologic identification. TRIAL REGISTRATION: ClinicalTrials.gov NCT05121805. Registered on 16 November 2021. Start recruitment: 17 March 2022. Planned completion of recruitment: 31 April 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kemper G, Gerges C, Schoon EJ, et al. Recurrences of advanced sessile and lateral spreading colorectal adenoma after endoscopic mucosal resection (EMR) thermal ablation versus no adjuvant therapy (RESPECT): a protocol of an international randomized controlled trial. Trials. 2024. PMID: 38368409. doi:10.1186/s13063-024-07915-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。